HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Barbara Sennino Selected Research

2- (4- (3- quinolin- 6- ylmethyl- 3H- (1,2,3)triazolo(4,5- b)pyrazin- 5- yl)pyrazol- 1- yl)ethanol

6/2013Inhibition of c-Met reduces lymphatic metastasis in RIP-Tag2 transgenic mice.
3/2012Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Barbara Sennino Research Topics

Disease

20Neoplasms (Cancer)
01/2018 - 04/2002
4Neoplasm Metastasis (Metastasis)
01/2018 - 07/2011
4Carcinoma (Carcinomatosis)
06/2011 - 10/2006
3Hypoxia (Hypoxemia)
10/2012 - 07/2011
2Neuroendocrine Tumors (Neuroendocrine Tumor)
06/2013 - 03/2012
2Breast Neoplasms (Breast Cancer)
01/2009 - 05/2008
1Infections
01/2018
1Renal Cell Carcinoma (Grawitz Tumor)
01/2015
1Lymphatic Metastasis
06/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
03/2012
1Lewis Lung Carcinoma
06/2011
1Ovarian Neoplasms (Ovarian Cancer)
02/2010
1Hemorrhage
07/2008
1Hematologic Neoplasms (Hematological Malignancy)
05/2008
1Arthritis (Polyarthritis)
05/2007
1Inflammation (Inflammations)
07/2003
1Adenocarcinoma
06/2003
1Necrosis
06/2003

Drug/Important Bio-Agent (IBA)

13Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015 - 06/2003
4Sunitinib (Sutent)FDA Link
01/2018 - 03/2012
4Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2015 - 10/2006
3Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2015 - 07/2011
3Angiogenesis InhibitorsIBA
07/2011 - 05/2008
3LectinsIBA
06/2011 - 05/2008
2Axitinib (AG 013736)IBA
01/2015 - 10/2006
2CrizotinibIBA
01/2015 - 03/2012
22- (4- (3- quinolin- 6- ylmethyl- 3H- (1,2,3)triazolo(4,5- b)pyrazin- 5- yl)pyrazol- 1- yl)ethanolIBA
06/2013 - 03/2012
2Contrast MediaIBA
05/2012 - 09/2009
2cabozantinibIBA
03/2012 - 07/2011
2Pharmaceutical PreparationsIBA
07/2011 - 06/2011
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
06/2011 - 08/2007
2Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
06/2011 - 08/2007
2Platelet-Derived Growth FactorIBA
05/2009 - 08/2007
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2009 - 06/2003
2StreptavidinIBA
01/2009 - 05/2008
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2018
1AntigensIBA
01/2016
1Immune Checkpoint InhibitorsIBA
01/2016
1Neoplasm Antigens (Tumor Antigens)IBA
01/2016
1Tyrosine Kinase InhibitorsIBA
01/2015
1montirelin (NS-3)IBA
05/2012
1Phosphotransferases (Kinase)IBA
07/2011
1GSK 1363089IBA
07/2011
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2011
1Imatinib Mesylate (Gleevec)FDA Link
06/2011
1bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
06/2011
1Nucleotide AptamersIBA
06/2011
1AlbuminsIBA
09/2009
1Thalidomide (Thalomid)FDA Link
01/2009
1Becaplermin (PDGF-BB)FDA Link
07/2008
1Messenger RNA (mRNA)IBA
07/2008
1Biomarkers (Surrogate Marker)IBA
05/2008
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
05/2008
1Bevacizumab (Avastin)FDA Link
05/2008
1Fixatives (Pickling Agents)IBA
05/2008
1Biotin (Vitamin H)FDA Link
05/2008
1Coloring Agents (Dyes)IBA
05/2008
1albumin-(gadolinium-DTPA)IBA
05/2008
1OligonucleotidesIBA
08/2007
1DNA (Deoxyribonucleic Acid)IBA
08/2007
1DesminIBA
08/2007
1gadofluorineIBA
05/2007
1OsteopontinIBA
07/2003
1Extracellular Matrix ProteinsIBA
07/2003
1CytokinesIBA
07/2003
1Complementary DNA (cDNA)IBA
06/2003
1Tetracycline (Achromycin)FDA LinkGeneric
06/2003
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
06/2003

Therapy/Procedure

11Therapeutics
01/2018 - 04/2002
2Drug Therapy (Chemotherapy)
10/2012 - 06/2011
1Intravenous Injections
01/2018
1Immunotherapy
01/2016
1Aftercare (After-Treatment)
10/2006